230 related articles for article (PubMed ID: 17440634)
1. Chemopreventive promise of targeting the Nrf2 pathway.
Yates MS; Kensler TW
Drug News Perspect; 2007 Mar; 20(2):109-17. PubMed ID: 17440634
[TBL] [Abstract][Full Text] [Related]
2. Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway.
Hayes JD; McMahon M; Chowdhry S; Dinkova-Kostova AT
Antioxid Redox Signal; 2010 Dec; 13(11):1713-48. PubMed ID: 20446772
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention through the Keap1-Nrf2 signaling pathway by phase 2 enzyme inducers.
Kwak MK; Wakabayashi N; Kensler TW
Mutat Res; 2004 Nov; 555(1-2):133-48. PubMed ID: 15476857
[TBL] [Abstract][Full Text] [Related]
4. Toward clinical application of the Keap1-Nrf2 pathway.
Suzuki T; Motohashi H; Yamamoto M
Trends Pharmacol Sci; 2013 Jun; 34(6):340-6. PubMed ID: 23664668
[TBL] [Abstract][Full Text] [Related]
5. Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents.
Giudice A; Arra C; Turco MC
Methods Mol Biol; 2010; 647():37-74. PubMed ID: 20694660
[TBL] [Abstract][Full Text] [Related]
6. Role of the Keap1-Nrf2 pathway in cancer.
Leinonen HM; Kansanen E; Pölönen P; Heinäniemi M; Levonen AL
Adv Cancer Res; 2014; 122():281-320. PubMed ID: 24974185
[TBL] [Abstract][Full Text] [Related]
7. Regulation of NF-E2-related factor 2 signaling for cancer chemoprevention: antioxidant coupled with antiinflammatory.
Hu R; Saw CL; Yu R; Kong AN
Antioxid Redox Signal; 2010 Dec; 13(11):1679-98. PubMed ID: 20486765
[TBL] [Abstract][Full Text] [Related]
8. Targeting NRF2 signaling for cancer chemoprevention.
Kwak MK; Kensler TW
Toxicol Appl Pharmacol; 2010 Apr; 244(1):66-76. PubMed ID: 19732782
[TBL] [Abstract][Full Text] [Related]
9. Targeting Nrf2-Keap1 signaling for chemoprevention of skin carcinogenesis with bioactive phytochemicals.
Chun KS; Kundu J; Kundu JK; Surh YJ
Toxicol Lett; 2014 Aug; 229(1):73-84. PubMed ID: 24875534
[TBL] [Abstract][Full Text] [Related]
10. Role of the Keap1/Nrf2 pathway in neurodegenerative diseases.
Yamazaki H; Tanji K; Wakabayashi K; Matsuura S; Itoh K
Pathol Int; 2015 May; 65(5):210-9. PubMed ID: 25707882
[TBL] [Abstract][Full Text] [Related]
11. Butylated hydroxyanisole regulates ARE-mediated gene expression via Nrf2 coupled with ERK and JNK signaling pathway in HepG2 cells.
Yuan X; Xu C; Pan Z; Keum YS; Kim JH; Shen G; Yu S; Oo KT; Ma J; Kong AN
Mol Carcinog; 2006 Nov; 45(11):841-50. PubMed ID: 16739127
[TBL] [Abstract][Full Text] [Related]
12. Nrf2: a potential molecular target for cancer chemoprevention by natural compounds.
Jeong WS; Jun M; Kong AN
Antioxid Redox Signal; 2006; 8(1-2):99-106. PubMed ID: 16487042
[TBL] [Abstract][Full Text] [Related]
13. Nrf2 as a target for cancer chemoprevention.
Yu X; Kensler T
Mutat Res; 2005 Dec; 591(1-2):93-102. PubMed ID: 16054659
[TBL] [Abstract][Full Text] [Related]
14. Contradictory roles of Nrf2/Keap1 signaling pathway in cancer prevention/promotion and chemoresistance.
Jeddi F; Soozangar N; Sadeghi MR; Somi MH; Samadi N
DNA Repair (Amst); 2017 Jun; 54():13-21. PubMed ID: 28415030
[TBL] [Abstract][Full Text] [Related]
15. Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2.
Sun Z; Zhang S; Chan JY; Zhang DD
Mol Cell Biol; 2007 Sep; 27(18):6334-49. PubMed ID: 17636022
[TBL] [Abstract][Full Text] [Related]
16. The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases.
Joshi G; Johnson JA
Recent Pat CNS Drug Discov; 2012 Dec; 7(3):218-29. PubMed ID: 22742419
[TBL] [Abstract][Full Text] [Related]
17. Nrf2-keap1 system versus NF-κB: the good and the evil in chronic kidney disease?
Pedruzzi LM; Stockler-Pinto MB; Leite M; Mafra D
Biochimie; 2012 Dec; 94(12):2461-6. PubMed ID: 22874821
[TBL] [Abstract][Full Text] [Related]
18. Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in Drosophila.
Sykiotis GP; Bohmann D
Dev Cell; 2008 Jan; 14(1):76-85. PubMed ID: 18194654
[TBL] [Abstract][Full Text] [Related]
19. An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy.
Zhu J; Wang H; Chen F; Fu J; Xu Y; Hou Y; Kou HH; Zhai C; Nelson MB; Zhang Q; Andersen ME; Pi J
Free Radic Biol Med; 2016 Oct; 99():544-556. PubMed ID: 27634172
[TBL] [Abstract][Full Text] [Related]
20. Design and development of Nrf2 modulators for cancer chemoprevention and therapy: a review.
Sova M; Saso L
Drug Des Devel Ther; 2018; 12():3181-3197. PubMed ID: 30288023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
